Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Program
On WRAL Monday at 6: Known carcinogens hiding in your childâs classroom? WRAL Investigates why some local schools are refusing to take action
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Selecta Biosciences
(NQ:
SELB
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EST, Nov 13, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
-
Bid (Size)
0.8900 (5)
Ask (Size)
0.9000 (10)
Prev. Close
0.8812
Today's Range
N/A - N/A
52wk Range
0.9366 - 1.300
Shares Outstanding
115,079,292
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: WaveDancer, Inc. (Nasdaq – WAVD), Selecta Biosciences, Inc. (Nasdaq – SELB), Graphite Bio, Inc. (Nasdaq – GRPH), CapStar Financial Holdings, Inc. (Nasdaq – CSTR)
November 16, 2023
From
Brodsky & Smith LLC
Via
GlobeNewswire
Selecta Biosciences Merges Cartesian To Focus On Autoimmune Cell Therapy
November 13, 2023
Selecta Biosciences Inc (NASDAQ: SELB) and Cartesian Therapeutics Inc announced a reverse merger in an all-stock deal, with Selecta shareholders owning
Via
Benzinga
Performance
More News
Read More
Analyst Ratings for Selecta Biosciences
August 18, 2023
Via
Benzinga
Selecta Biosciences Narrows R&D Focus On Gout Candidate
August 17, 2023
Via
Benzinga
Recap: Selecta Biosciences Q1 Earnings
May 04, 2023
Via
Benzinga
What 6 Analyst Ratings Have To Say About Selecta Biosciences
April 13, 2023
Via
Benzinga
The Latest Analyst Ratings for Selecta Biosciences
March 22, 2023
Via
Benzinga
Selecta Biosciences Earnings Perspective: Return On Capital Employed
March 08, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 18, 2023
August 18, 2023
Via
Benzinga
Selecta, SOBI's Chronic Refractory Gout Program Meets Primary Goal, US Submission Expected Next Year
March 21, 2023
Via
Benzinga
Why Cerberus Cyber Sentinel Shares Are Trading Higher By 147%; Here Are 20 Stocks Moving Premarket
March 21, 2023
Via
Benzinga
Earnings Preview For Selecta Biosciences
March 01, 2023
Via
Benzinga
5 Value Stocks In The Healthcare Sector
February 13, 2023
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
March 21, 2023
Via
InvestorPlace
The 7 Best Biotech Stocks to Buy for February 2023
February 07, 2023
Via
InvestorPlace
Analyst Says Selecta Biosciences' Gout Candidate Can Potentially Raise The Bar On Several Fronts
January 31, 2023
Via
Benzinga
Selecta Biosciences's Return On Capital Employed Insights
November 23, 2022
Via
Benzinga
A Look Into Healthcare Sector Value Stocks
November 21, 2022
Via
Benzinga
Selecta Biosciences: Q3 Earnings Insights
November 03, 2022
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
November 17, 2022
Via
Benzinga
Selecta Biosciences's Earnings Outlook
November 02, 2022
Via
Benzinga
Why Rogers Shares Are Trading Sharply Lower; Here Are 33 Stocks Moving Premarket
November 02, 2022
Via
Benzinga
Match Group, Super Micro Computer And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
November 02, 2022
Via
Benzinga
Earnings Scheduled For November 3, 2022
November 03, 2022
Via
Benzinga
Selecta Biosciences's Return On Capital Employed Overview
August 22, 2022
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.